Healthier Choices Management (HCMC) AI Stock Analysis

• Market Cap: $24.06M
• Dividend Yield: N/A
• Average Volume (3M): N/A
• Price to Earnings (P/E): ―
• Beta (1Y): -41.50
• Revenue Growth: -99.99%
• EPS Growth: N/A
• Country: US
• Employees: 143
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Grocery Stores
• EPS (TTM): N/A
• Shares Outstanding: 481,266,630,000
• 10 Day Avg. Volume: N/A
• 30 Day Avg. Volume: N/A
• PEG Ratio: <0.01
• Price to Book (P/B): -0.31
• Price to Sales (P/S): 957.48
• P/FCF Ratio: -0.12
• Enterprise Value/Market Cap: 0.95
• Enterprise Value/Revenue: 7.32K
• Enterprise Value/Gross Profit: -258.40
• Enterprise Value/Ebitda: -2.74
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 41 Neutral
• Price Target: $0.01 ―
• Action: Upgraded Date: 12/30/25
• Date: Action: Upgraded 12/30/25

The score is driven primarily by extremely weak financial performance, including a severe revenue collapse, negative gross profit, large continuing losses, negative equity, and ongoing cash burn. Technical and valuation inputs are largely unavailable, so they have limited impact on the final score.

Positive Factors

Diversified Revenue Streams

The company's diversified revenue streams, including health products and CBD, provide resilience against market fluctuations and sector-specific downturns.

CBD Market Potential

HCMC's focus on the growing CBD market positions it to benefit from increasing consumer demand for natural health solutions, potentially driving future growth.

Strategic Partnerships

Strategic partnerships can enhance product distribution and visibility, potentially leading to increased market share and revenue growth over time.

Negative Factors

Declining Revenues

Significant revenue decline indicates challenges in sustaining business operations and competitiveness, threatening long-term viability.

Negative Profit Margins

Persistent negative profit margins suggest ongoing operational inefficiencies, impacting the company's ability to generate sustainable profits.

Precarious Balance Sheet

A precarious balance sheet with negative equity highlights financial instability, limiting the company's capacity to invest in growth and manage debt.

Healthier Choices Management Business Overview & Revenue Model

Company Description

Healthier Choices Management Corp. (HCMC) is a diversified company focused on improving health and wellness through a range of products and services. Operating primarily in the health and wellness sector, HCMC offers a variety of products including nutritional supplements, health foods, and alternative therapies. The company also explores opportunities in the cannabis industry, particularly in the production and distribution of CBD products, aiming to meet the growing consumer demand for natural health solutions.

How the Company Makes Money

HCMC generates revenue through multiple streams. Its primary revenue model includes the direct sale of health and wellness products, which encompasses nutritional supplements and health foods, often sold through retail and online platforms. Additionally, the company leverages its position in the cannabis sector by developing and selling CBD-infused products, capitalizing on the increasing legalization and acceptance of cannabis-related goods. HCMC also explores strategic partnerships with other health-focused brands and retailers to enhance product distribution and visibility. Furthermore, the company may engage in marketing and promotional activities that drive consumer awareness and sales, contributing to its overall revenue.

Healthier Choices Management Financial Statement Overview

Summary

Financial performance is extremely weak: revenue collapsed from $29.3M (2022) to near-zero ($501 in 2024; $2.9K TTM), gross profit is negative in 2023–TTM, and losses remain large (net loss ~-$8.4M TTM). Despite a major reduction in debt, the balance sheet shows negative equity in 2024/TTM and cash flow remains deeply negative (operating cash flow ~-$4.7M TTM), indicating ongoing cash burn and elevated financial risk.

Income Statement

Operating performance is extremely weak. Revenue has collapsed from $29.3M (2022) to just $501 (2024) and $2.9K in TTM (Trailing-Twelve-Months), with negative growth continuing. Profitability has deteriorated sharply: gross profit is negative in 2023–TTM and losses remain very large (net loss of ~$8.4M in TTM) relative to the tiny revenue base, indicating a cost structure that is not currently supported by sales. The main positive is that net losses have narrowed versus 2023–2024, but the business remains deeply unprofitable.

Balance Sheet

The balance sheet shows elevated risk due to negative equity in 2024 and TTM (Trailing-Twelve-Months), which signals that liabilities exceed assets and limits financial flexibility. Total debt has been reduced dramatically (from $14.9M in 2023 to ~$0.46M in 2024 and near-zero in TTM), which is a meaningful improvement. However, the negative equity position and shrinking asset base (down to ~$1.5M in TTM) outweigh the debt reduction and keep overall balance sheet quality weak.

Cash Flow

Cash generation remains materially negative, with operating cash flow of about -$4.7M in TTM (Trailing-Twelve-Months) and negative free cash flow as well, indicating ongoing cash burn. Free cash flow improved versus the prior year (positive growth rate), but it is improving from a deeply negative base rather than turning positive. With persistent operating outflows and continued net losses, the company likely relies on external funding or asset reductions to sustain operations.

Breakdown	TTM	Dec 2024	Dec 2023	Mar 2023	Mar 2022	Dec 2020
Income Statement
Total Revenue	3.13K	501.00	617.00	29.27M	13.32M	13.92M
Gross Profit	-88.79K	-66.31K	-80.29K	10.22M	5.29M	5.78M
EBITDA	-8.37M	-4.89M	-8.47M	-4.99M	-3.71M	-2.32M
Net Income	-8.43M	-11.89M	-18.48M	-7.22M	-4.04M	-3.72M
Balance Sheet
Total Assets	1.53M	2.22M	30.97M	55.26M	34.44M	11.87M
Cash, Cash Equivalents and Short-Term Investments	1.12M	1.19M	5.08M	22.92M	26.52M	948.21K
Total Debt	2.12K	457.67K	14.87M	13.64M	3.54M	8.51M
Total Liabilities	4.86M	3.78M	23.10M	35.05M	5.21M	9.62M
Stockholders Equity	-3.33M	-1.56M	7.87M	20.21M	29.23M	2.26M
Cash Flow
Free Cash Flow	-4.68M	-3.85M	-4.94M	-4.36M	-3.60M	-2.40M
Operating Cash Flow	-4.68M	-3.66M	-4.74M	-3.87M	-3.53M	-2.29M
Investing Cash Flow	0.00	-4.92M	-768.55K	-10.73M	-87.32K	-75.20K
Financing Cash Flow	2.82M	4.69M	-13.55M	12.79M	27.19M	1.76M

Healthier Choices Management Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
USNA	56 Neutral	$393.40M	38.43	3.20%	―	5.88%	-68.62%
ZVIA	46 Neutral	$100.51M	-8.73	-17.19%	―	6.17%	41.09%
HCWC	46 Neutral	$5.72M	―	―	―	―	―
WVVI	45 Neutral	$13.40M	-3.84	-1.79%	―	-4.82%	-14.60%
HCMC	41 Neutral	$24.06M	―	―	―	-99.99%	―
KAVL	39 Underperform	$338.38K	-0.02	-68.63%	―	-88.85%	68.28%